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lation, have provided important clinical and mechanistic in-Clinical and genetic epidemiology of inherited renal disease in
sights into inherited renal diseases.Newfoundland. Newfoundland’s geography, settlement, and so-
cioeconomic development have produced a population useful for
the study of genetic diseases. This review examines the clinical
and genetic epidemiologic studies of inherited renal diseases
undertaken in this population in the past 15 years. Common The Canadian province of Newfoundland is a large is-
founder effects and large families through each generation pro- land the size of Britain, located in the North Atlantic
vided very extensive pedigrees with autosomal-dominant dis-
with a population of 550,000. Its geography, settlement,eases, such as polycystic kidney disease (PKD) and von Hippel-
and socioeconomic development have produced a pop-Lindau disease. In the former disease the diagnostic utility of
renal ultrasound was determined, as was the prognostic impact ulation useful for study of genetic diseases [1]. Large
of genotype, the role of the renin-angiotensin system in the families, founder effects, and close family ties have facil-
pre-hypertensive phase, the potential for somatic mutations of
itated the investigation of very large families with auto-the PKD2 gene, or the combination of mutations in the PKD1
somal-dominant diseases, such as polycystic kidney dis-and PKD2 genes, in single cells to induce cysts, and the demon-
stration that human transheterozygotes of PKD1 and -2 are ease (ADPKD) and von Hippel-Lindau disease (VHL),
not embryonically lethal. The presence of multiple genetic iso- which can be studied in a situation where variations
lates and the high coefficient of kinship have predisposed to
created by genetic heterogeneity, geographic or ethnicautosomal recessive diseases such as Bardet-Biedl syndrome
variation, and ascertainment bias can be limited. In addi-(BBS), autosomal-recessive PKD, primary hyperoxaluria, and
dihydroxyadenine urolithiasis. We have reported the clinical tion to these factors, persistent genetic isolation, with
manifestations and natural history of the BBS, with particular a high coefficient of kinship [2, 3] has facilitated the
emphasis on the fact that renal abnormalities are cardinal mani- investigation of autosomal-recessive diseases such asfestations of the disease, the presence of at least six different
Bardet-Biedl syndrome (BBS). Furthermore, Newfound-genotypes, the identity and function of the BBS6 gene, and
the presence of three different BBS6 mutations. Because of its land’s genetically simplified isolates may be helpful for
relatively homogenous origins and high coefficient of kinship, the study of complex genetic diseases such as preeclamp-
Newfoundland’s population also may be useful for the study sia, diabetes mellitus, renal stone disease, and hyper-of complex diseases such as preeclampsia. Using unbiased ascer-
tension [4]. Genetic studies in very young founder pop-tainment and strict diagnostic criteria, we have found a significant
risk of preeclampsia and non-proteinuric gestational hyperten- ulations may exploit founder effects associated with
sion in sisters of probands with preeclampsia, particularly when higher allele frequency for linkage disequilibrium studies
probands are defined by severity of preeclampsia, an observa- [5], and inbreeding may increase the power to detecttion that supports a study to search for susceptibility genes.
disease susceptibility factors by comparison of genotypicWe conclude that collaborations between clinical epidemiolo-
gists and molecular geneticists, using the Newfoundland popu- distribution among cases and controls [6]. Although de-
mographic factors, such as inbreeding and population
homogeneity, increases linkage disequilibrium (the non-
1 Currently at Simon Fraser University, Burnaby, British Columbia, independence of alleles at different sites) [7], geneticallyCanada.
isolated populations are not necessarily a panacea for
Key words: Canadian renal disease, kinship study, autosomal-dominant linkage disequilibrium mapping of common disease
diseases, autosomal-recessive diseases, molecular genetics, Mendelian
genes [8].inherited disease.
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Table 1. Genetic causes of end-stage renal diseaseTHE SETTLING OF NEWFOUNDLAND
in 669 Newfoundland patients
The demand for cod in Europe spurred the migration
N %of settlers to Newfoundland, which occurred particularly
Autosomal-dominantin the late eighteenth century and early nineteenth cen-
Polycystic kidney disease 30 4.5
tury. Immigrants, originating from two highly localized Alport syndrome 18 2.7
Charcot-Marie-Tooth syndrome 2 0.3areas (Southwest England and Southeast Ireland), set-
Autosomal-recessivetled in coastal communities to prosecute the fishery [1].
Bardet-Biedl syndrome 2 0.3
The majority of the Irish was Catholic, originating within 2,8 Dihydroxyadenine stone disease 2 0.3
Hyperoxaluria 2 0.3a 30-mile radius of Waterford City. There were two major
Polycystic kidney disease 1 0.2migrations of Irish occurring before the Irish Famine of
Probable complexa
1845 to 1849: one between 1811 and 1816, and the other Hypertension 34 5.1
Diabetes mellitus 133 19.9between 1825 and 1833. The English maintained a rela-
Interstitial disease 70 10.5tively constant immigration and originated from Devon,
a Risk of renal failure in first degree relatives of probands 3 times greater thanDorset, Hampshire, and Somerset areas that contained
that in first-degree relatives of spousal controls [9]
ports involved in the Newfoundland migratory cod fish-
ery. The ratio of Irish to English settled on the island
was about even [1].
By the mid-1830s the major migrations had concluded, 1987 to 1993 (N  669) [9]. Detailed family histories
and the population of Newfoundland was about 75,000. were obtained from 584 (87%) ESRD probands and 499
Thereafter natural increase became the dominant mech- of their spouses, who served as a control group. Eight and
anism of population growth. By the twentieth century a half per cent of the probands had Mendelian inherited
the population was 221,000, by the early 1960s it had disease and no new cases of Mendelian disease were
doubled, and by 1984 it was at its peak of 581,800. It has identified. Causes of Mendelian inherited disease are
been estimated that 90% of the current population has shown in Table 1. Since 1994 three patients with von
arisen from 20,000 to 30,000 original settlers [1], the Hippel-Lindau disease have started dialysis.
homogeneity of whose origins has been suggested by In probands without Mendelian inherited disease,
historical geography, but not yet proven by population 1.2% of 5780 first degree relatives developed renal fail-
DNA studies. ure associated with death or requiring dialysis compared
In addition to geographic isolation, isolation of coastal to 0.4% of 3807 first degree relatives of spouses [relative
settlements was maintained by dependence on the fish- risk (RR)  3.0, 95% confidence intervals (97% CI)
ery, lack of roads, segregation by religion, and limited 1.7 to 5.2], suggesting inherited molecular factors may
immigration. Community expansion occurred predomi- contribute to the development of renal failure. The high-
nantly by partition of ancestral lands among heirs or by est rates of affected first degree relatives occurred in
movement to other nearby uninhabited lands near the probands with hypertensive renal failure (2.3%) and dia-
settlement core, which kept related families together [1]. betes mellitus (1.6%).
Even in 1982 50% of the population lived in communities
of less that 2500, and 41% in communities of less than
AUTOSOMAL-DOMINANT RENAL DISEASES1000 [2].
As a result of how Newfoundland was settled and Autosomal-dominant polycystic kidney disease
expanded, the Newfoundland population can be consid-
In the early 1980s 17 families with autosomal-domi-ered to have relatively homogenous origins and to consist
nant polycystic kidney disease (ADPKD) were identifiedof multiple genetically simplified isolates [4]. It is influ-
following communication with all the urologists andenced by founder effects and a high coefficient of kinship
nephrologists in Newfoundland [10]. In 166 family mem-[2, 3]. Investigation of genetic diseases has been facili-
bers with cysts, the average age to ESRD or death wastated by large families, close family ties, modest out
59  2 years (mean  SE), whereas in 340 membersmigration, and a modern health care system.
without cysts it was 74  2 [9]. Through linkage studies,
it was determined that in 10 families the presence of
END-STAGE RENAL DISEASE renal cysts cosegregated with polymorphic DNA mark-
ers flanking the PKD1 locus on chromosome 16, andTo determine the impact of Mendelian inherited dis-
these families had PKD1. Two families did not cosegre-ease on the development of end-stage renal disease
gate with PKD1 markers, and five were uninformative.(ESRD) in Newfoundland, and to assess the risk of renal
The outcome for family members with PKD1 was morefailure in first degree relatives of probands with ESRD,
severe than for those known not to have PKD1, in thatwe identified all patients in Newfoundland who had
ESRD in 1987 and subsequently developed ESRD from age to ESRD or death in the former (N 134) was 57
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Table 2. Diagnostic utility of renal cysts detected by ultrasound in to 10 family members without PKD1 (mean BP  113/
PKD1 family members at 50% risk of autosomal-dominant
69) [13]. We concluded that increased intrarenal, andpolycystic kidney disease (ADPKD) who had PKD1 gene status
inferred from a haplotype at the PKD1 locus [11] possibly systemic renin-angiotensin activity, precedes
and may contribute to the development of hypertensionUltrasonographic results
in PKD1 [13].
Genotype Renal cysts No cysts Equivocal
PKD2. In collaboration with York Pei in Toronto,
Age 30 years mechanisms associated with the development of cysts in
PKD1 40 7 1
non-PKD1 families were explored. In one of these fami-Normal 0 22 1
Age 30 years lies markers around the PKD2 locus on chromosome 4
PKD1 27 0 0 cosegregated with the presence of renal cysts [14]. A
Normal 0 22 6
mutation in the PKD2 gene (1510 del 127) caused a 27
base-pair deletion, which deleted nine amino acids at
the junction of first intracellular loop and third trans-
membrane domain of polycystin 2, causing a misfolding2 years and in the latter (N  18) it was 69  2 (P for
of the encoded protein. One of the family members de-difference  0.003) [11].
veloped intractable renal pain and, following nephrec-PKD1. In PKD1 families the diagnostic utility of renal
tomy, the kidney was sent to Dr. Pei, whose group pro-ultrasound was studied in 126 people with a 50% risk of
ceeded to examine the hypothesis that somatic PKD2inheriting the mutation, in whom their genotypes were
mutations in individual renal cysts produce a secondinferred from linkage studies (Table 2). Discordance be-
hit, which together with the germline mutation inducestween the negative ultrasound findings and genotype was
clonal expansion of cells that eventually results in a cystage dependent: 17% of those less than 30 years who
[15, 16]. This model is not universally accepted becauseinherited the PKD1 did not yet have cysts, whereas all
expression studies have shown up-regulation of PKD1
27 persons 30 years or older did have cysts, suggesting
mRNA and protein in cystic tissue (references in [16]).
a low probability of a false-negative ultrasonographic
Somatic mutations of PKD2 were found in 71% of 28
diagnosis in persons 30 years or older [12]. PKD2 cysts obtained from two kidneys [16]. The muta-
In PKD1 families the resemblance in age of onset of tions were randomly distributed and no two were identi-
ESRD was apparent. In five families with four or more cal. It was possible to determine that in 10 of 20 cysts
members with ESRD there was less variation in age of the wild-type PKD2 allele had acquired the mutation.
onset of ESRD within than between families. Nonethe- These findings are consistent with the idea that somatic
less, the variation in age of onset within families was mutation is an integral step in the pathogenesis of
substantial [12]. To determine whether the specific muta- ADPKD, and that germline and somatic inactivation of
tion, or perhaps modifying genes, could influence the both copies of polycystin 2 confer growth advantages for
outcome of ADPKD we have undertaken extensive hap- an individual cell to clonally expand to a cyst. Of even
lotype analysis around the PKD1 locus to search for greater interest was the observation that three PKD2
families with a common founder. Initial results suggest cysts, in which comprehensive screening had failed to
a founder effect linking four families along the south identify a somatic PKD2 mutation, actually had somatic
coast of Newfoundland (comprising 91 affected family PKD1 mutations. The combination of mutations in the
members) and four other families with four different PKD1 and PKD2 genes in single cysts suggests an inter-
mutations comprising 54 affected family members (Fig. 1) action of the two gene products, so that where trans-
(abstract; Parfrey et al, J Am Soc Nephrol 12:236A, heterozygous mutations occur they also confer a growth
2001). These founder effects thus provide a very large advantage [16]. It is not clear why the functionally hap-
pedigree who probably have the same mutation, who live loid state for each of the locus gene products should
in the same geographic area, and have family members mimic a null state for one of the locus gene products.
identified without ascertainment bias, a situation that Perhaps the trans-heterozygous loss of function at the
may permit the identification of factors that modify the somatic level may be sufficient to disrupt the signaling
outcome of ADPKD. pathway in which the proteins participate.
In PKD1 families the prevalence of hypertension be- Haplotype analysis and sequencing of the PKD2 gene
low the age of 40 (N  68) was 27% and between 40 has identified the previous family and a second family
and 59 years (N  18) it was 61% [11]. To investigate to have the same founder mutation, two other families
the role of the renin-angiotensin system in the develop- to have two different PKD2 mutations, and a fifth fam-
ment of hypertension, we studied 17 family members ily to have digenic ADPKD (Fig. 1) (abstract; Parfrey
with PKD1 who were normotensive (mean BP 121/75) et al, J Am Soc Nephrol 12:236A, 2001). In the latter
and did not have renal impairment (creatinine clearance family 48 members were studied, 28 of whom had PKD
[17]. Using single stranded conformational analysis a70 mL/min, mean 109 mL/min), and compared them
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Fig. 1. Geographic distribution of PKD1 and
PKD2 families in Newfoundland. Mutation
status, inferred by haplotype analysis, is noted
by bracketed letter. The four families with the
identical haplotype around the PKD1, trans-
mitted with PKD, locus are labeled PKD1 (A).
PKD2 mutation was found in 12 affected family mem- chromocytoma (53%), and cerebellar hemangioblastoma
(18%). Seven patients with renal cysts were diagnosedbers. When the disease status of these individuals was
coded as unknown in linkage analysis, significant lod and one had renal cell carcinoma. An annual screening
protocol was started which included ultrasonography ofscores were obtained with markers at the PKD1 locus,
strongly supporting the presence of an independently kidneys and baseline computed tomography (CT) scan-
ning of kidneys of individuals in their mid-20s.segregating PKD1 mutation in 15 other affected mem-
bers without the PKD2 mutation. In addition, two af- A study is in progress to determine the impact of
screening in Newfoundland families with VHL. Prior tofected individuals had both mutations, and both had
more severe renal disease than other affected individuals screening 90% of those affected were diagnosed by age
41 years, the majority being symptomatic at that time,with either mutation alone. This first documentation of
digenic ADPKD demonstrates that human trans-hetero- whereas following initiation of screening 90% of affected
were identified by age 26 years, the majority of whomzygotes are not embryonically lethal [17].
were asymptomatic at this time [19]. Following initiation
Alport syndrome of screening 33% were subsequently diagnosed with re-
nal cell carcinoma, the surgical management of whichSix families with this disorder have been identified,
subsequently led to the presentation of three VHL pa-four of whom have X-linked inheritance. In the two other
tients to the dialysis unit. One of the three patients diedfamilies inheritance pattern cannot be categorized. DNA
has been collected on all six families, but mutation analy- within one year from metastatic disease, and two have
sis has not been completed. survived for five years.
Detailed genetic mapping of the VHL disease gene to
von Hippel-Lindau disease chromosome 3p25-p26 enabled pre-symptomatic diag-
nosis of VHL disease by polymorphic DNA markers invon Hippel-Lindau (VHL) disease, an autosomal-dom-
inant disorder, with complete penetrance, was diagnosed our family [20, 21]. Identification of the VHL disease
gene provided the opportunity to develop molecular ge-in a large Newfoundland pedigree. A collaborative initi-
ative was begun in 1982 to improve management of the netic diagnosis of VHL disease by direct molecular anal-
ysis. In our family the C→T transition at nt712 abolisheddisease, and 38 family members with VHL were iden-
tified initially [18]. The most common manifestations an MspI site, and was used to initially screen 41 family
members for this missense mutation [22]. All 14 affectedwere retinal angioma (present in 60% of affected), pheo-
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Fig. 2. Geographic distribution of Bardet-Biedl
syndrome (BBS) in Newfoundland families by
identification numbers (B1–B19) and by geno-
type (BBS1-6).
Table 3. Clinical manifestations of Bardet-Biedl syndromerelatives had the mutation, and it was absent in 23 of 27
in Newfoundland [26]
at-risk relatives.
NIn VHL missense mutations, rather than large dele-
Tested Affected % Affectedtions, a predisposition to pheochromocytoma, particu-
larly the substitution of an arginine at codon 238, has Cardinal manifestations
Syndactyly and/or polydactyly 31 29 93occurred in our family [21]. However, there was no evi-
Obesity 25 24 95dence of a generalized increase in age related cancer risks
Retinal dystrophy 28 28 100
for missense mutations (including renal cell carcinoma), Male hypogenitalism 8 7 88
Renal caliceal anomalies 23 22 96suggesting that missense mutations predisposing to pheo-
Other important manifestationschromocytoma have tissue-specific effects [23].
Polydactyly alone 31 18 58
Retinitis pigmentosa 26 2 8
Charcot-Marie-Tooth disease Mental retardation 32 13 41
Vaginal atresia 12 2 17This hereditary neuropathy is characterized by pero-
Diabetes mellitus by glucose
neal muscular atrophy in which renal disease occasion- tolerance test 20 9 45
ally occurs. The two cases of Charcot-Marie-Tooth dis-
ease recorded in Table 1 were a mother and child who
both developed ESRD, the mother at 28 years and
daughter in her mid-teens [24]. Kidney biopsy at an early characterized by obesity and by dystrophy of the hands,
stage of nephropathy in the daughter revealed focal seg- eyes, kidneys, and male genitalia [26]. It has a high preva-
mental proliferative glomerulonephritis. It is possible lence in Newfoundland, 1 in 17,500 of the population,
that both the neuropathy and the renal disease are associ- and has occurred in multiple communities scattered
ated genetically. around the coast (Fig. 2).
BBS phenotype. In mid-1980s 32 BBS patients were
identified in Newfoundland, primarily through the Cana-AUTOSOMAL-RECESSIVE RENAL DISEASES
dian National Institute of the Blind, and an extensive
Bardet-Biedl syndrome array of investigations were undertaken to determine the
Bardet-Biedl syndrome (BBS) has previously been clinical manifestations of BBS [26–28]. The prevalence of
known as Laurence-Moon-Biedl syndrome, but is cur- various clinical manifestations is presented in Table 3
rently differentiated clinically from Laurence Moon syn- [26]. One hundred per cent of those examined had severe
retinal dystrophy, but only 2 of 28 had typical retin-drome [25]. BBS is an autosomal-recessive condition
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Table 4. Renal abnormalities in Newfoundland patients






blunting 23 22 96
Calycal cysts/
diverticula 23 17 74
Fetal type lobulation 21 20 95
Diffuse cortical scarring 21 6 29
Functional
Hypertension 36 25 66
Chronic renal
insufficiency 36 9 25
End-stage renal disease 36 4 11 Fig. 3. Age of diagnosis of blindness (), hypertension (), and renal
Partial defect in urine impairment () in Bardet-Biedl syndrome patients.
concentration 17 14 82
Renal tubular acidosis
Incomplete 19 5 26
Complete 19 1 5
years, and 50% by 18 years (Fig. 3). Twenty-five patients
(66%) had hypertension, 25% by age 26 years, 50% by
age 34 (Fig. 3), whereas in the unaffected group 25%
had hypertension by age 49 years (P  0.0001). Nineitis pigmentosa. Polydactyly was present in 58% but syn-
(25%) BBS patients developed renal impairment, withdactyly, brachydactyly, or both was present in all. Obe-
25% affected by age 48 years (Fig. 3). Eight patientssity was present in all but one of patient. Only 41% were
with BBS died, three with ESRD and three with chronic
considered mentally retarded. Scores on verbal subtests
renal failure. On the life-table analysis 25% of BBS had
of intelligence were usually lower than scores of per- died by 44 years, whereas at that age 98% of unaffected
formance tasks. Seven of eight men had small testes and siblings were still alive (P  0.0001). Thus, not only are
genitalia that were not due to hypogonadotropism. All 12 renal structural and/or functional abnormalities cardinal
women had menstrual irregularities and endocrinologic manifestations of BBS, renal impairment is frequent and
evidence of reproductive dysfunction. Two women had an important cause of death, which contributes to the
vaginal atresia, but two other women had live births. substantially reduced survival.
Diabetes mellitus was present in 45%. Renal structural BBS genotypes. By the mid-1990s four different BBS
or functional lesions were universal. It was concluded loci had been identified. The critical locus for BBS1 had
that the cardinal manifestations of BBS were dystro- been positioned to chromosome 11q13 [30], BBS2 to
chromosome 16q21 [31], BBS3 to chromosome 3p13-phic extremities, obesity, retinal dystrophy, renal anoma-
p12 [32], and BBS4 to 15q22.3-q23 [33]. Therefore, welies, and male hypogenitalism, and that mental retarda-
decided to determine the contribution of each of thesetion, polydactyly, and retinitis pigmentosa were not [26].
genotypes to BBS in Newfoundland [34]. DNA was ob-Of those who underwent a renal investigation, 82%
tained from 17 families with 36 BBS individuals. Twelvecould not concentrate above 750 mOsm/kg even after
families had at least two affected members, consanguin-vasopressin, 26% failed to get urinary pH below 5.3 after
ity was observed in five (29%) families, and suspectedammonium chloride administration, 96% had calyceal
in a further seven (41%). Two-point linkage was soughtclubbing or blunting, 74% calyceal cysts or diverticula,
at each of the four known BBS loci, and haplotype analy-95% had lobulated renal outlines of the fetal type, and
sis was performed in 34 affected and 111 unaffected29% had diffuse renal cortical loss (Table 4) [27, 28].
family members. In this study three (18%) families were
Renal structural abnormalities were best imaged by in- assigned to BBS1, one (6%) family was suggested as
travenous urography, rather than renal ultrasound [27]. being BBS2, another (6%) was assigned to BBS3, and
Only one of 18 voiding cystourethrograms revealed vesi- six (35%) families were excluded from each of the four
coureteric reflux [27], suggesting that the calyceal abnor- known loci [34]. It was concluded that a fifth locus for
malities arose from intrinsic renal disease. BBS exists.
The natural history of BBS1 was further explored in BBS1. To further investigate the role of BBS1 in New-
the mid-1990s in a prospective cohort of 38 patients with foundland extensive genotyping was undertaken in the
BBS and 58 unaffected siblings [29]. All but five patients three BBS1 families already identified and in a further
three families in whom BBS1 was not excluded, as they(86%) were legally blind, 25% being blind by age 13
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Table 5. Bardet-Biedl syndrome genotypeshad positive lod scores for BBS1 markers and haplotypes
in Newfoundland [35, 37–39]
consistent with linkage to BBS1 [35]. Eight BBS patients
Genotype N families % totaland 44 unaffected family members were studied. An
BBS1 6a 35intrafamilial recombination in the disease haplotype nar-
BBS2 (probable) 1 6rowed the critical locus to 15 cM between D11S1883 and
BBS3 1 6
FGF3. Extensive genotyping identified a 1 cM ancestral BBS5 1 6
BBS6 5 29haplotype between D11S1883 and D11S4940 surround-
Non-BBS1-6 1 6ing PYGM. The fact that all BBS1 patients in the New-
Uninformative 2 12
foundland population are homozygous for this rare hap- Total 17 100
lotype suggests a founder effect. Furthermore, five of the a One of these families is being investigated further to determine whether it
is BBS1 or BBS2six BBS1 families reside on the south and southwest coast
of the island (Fig. 2), a region that was settled predomi-
nantly by the spread of settlers by sea in an east to west
direction [36]. The identification of a small (1 cM), se-
ation also was found in the heterozygous state in two otherquence ready, region on chromosome 11q13, which could
families, and it segregated with the haplotype-inferredenable the identification of the BBS1 gene, stimulated
prediction of a common ancestral chromosome in thesea collaboration with Dr. Katsanis and Dr. Lupski in
four pedigrees. The second disease-associated allele in oneHouston and Dr. Philip Beales in London, who had the
of these families was a T→C transition, and in the otherskills and technology to identify genes within this region.
it was a complex 429 CT  433 AG allele. The fifthBBS3. This Newfoundland kindred was the second
family was homozygous for this latter mutation. It wasBBS3 family described in the literature. Refined map-
concluded that the MKKS gene was also the BBS6 gene.ping around the BBS3 locus in this Newfoundland kin-
The MKKS protein is probably a type II chaperonindred with five BBS3 patients reduced the critical region
responsible for folding of proteins. Two of the three New-of BBS3 to a 6 cM region between D3S1595 and
foundland BBS6 mutations were deletions, which resultD3S1753. No evidence of a distinct BBS3 specific pheno-
in severely truncated proteins, which likely abolish thetype was obtained [37].
ability to fold target proteins. It is likely that the thirdBBS5. In one of six families not linked to BBS1-4 a
mutation, a missense mutation, results in a functionallygenome wide scan with 370 DNA markers, spaced about
null protein [39]. It appears that the MKKS protein is im-10 cM apart, was conducted using DNA pools of patients,
portant in the final development of multiple organs, par-parents, and siblings. A fifth locus (BBS5) was positioned
ticularly as mutations in the MKKS gene are associatedto chromosome 2q31 in a family with five affected mem-
with dystrophy of the hands, kidneys, eyes, and genitalia,bers and three consanguineous unions [38]. Using DNA
and with obesity.from four BBS patients, four parents, and 11 unaffected
BBS2. In the family designated probable BBS2 (onsiblings a lod score of 5.7 was obtained for BBS5 and
the basis of lod score and haplotype homozygosity) anmarker D2S1353 on chromosome 2q31. The critical re-
unusual A242S missense mutation also was observed ingion was located in a 13 cM interval between D2S156
one BBS6 gene but not in the other allele [41]. Unaf-and D2S1238.
fected sibs had the same haplotype at the BBS6 locus.BBS6. In one of the BBS families not linked to BBS1-5
Although we believe this family probably has BBS2, ita lod score of 1.91 was obtained for BBS and D20S189
is possible that the A242S mutation of BBS6 could acton chromosome 20p12, with homozygosity exclusively
in conjunction with mutations at other loci to producein two BBS patients but not in four unaffected siblings
the BBS phenotype.[38]. Genotyping with D20S189 in five families excluded
Genetic heterogeneity of BBS. Of the 17 Newfound-from BBS1-5 (9 BBS patients) produced a significant
land families who participated in genetic studies, six dif-cumulative lod score of 3.9, indicating a sixth BBS locus
ferent BBS loci were identified, 35% of families hadat 20p12 [39]. Haplotype analysis identified a 1.9 cM
BBS1 and 29% had BBS 6 (Table 5). One family hascritical region between D20S851 and D20S189. The col-
been excluded from BBS1-6, implying that a seventhlaboration with Houston now paid off. A gene for McKu-
BBS locus exists. Furthermore, in the five BBS6 families,sick-Kaufman syndrome (MKKS) had recently been
three different mutations were observed. This surprisingidentified in the same region of 20p [40]. Given the over-
degree of genetic heterogeneity in the Newfoundlandlapping phenotype for MKKS and BBS (particularly for
population is compatible with the identification of BBShydrometrocolpos and polydactyly) it was hypothesized
all around the coast of Newfoundland rather than in athat the MKKS gene was a candidate for BBS6.
single geographic cluster (Fig. 2), suggesting that theFollowing sequencing of the MKKS gene it was discov-
Newfoundland population is composed of multiple ge-ered that affected individuals from two pedigrees were
homozygous for the deletion 280 T [39]. The same alter- netically simplified isolates, and that the multiple BBS
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genes involved in an important developmental pathway COMPLEX DISEASES
may be particularly subject to mutations. In addition, Pregnancy-induced hypertension
it is possible that heterozygotes have obtained survival Preeclampsia. Preeclampsia (PE) is an important
advantage. For example, the ability to store fat may have cause of morbidity and mortality in both mothers and
provided a survival benefit in a cold harsh climate, where newborns. Modest progress in determining its etiology
there was uncertainty about the availability of food. We has occurred, although it is likely that an inherited predis-
are currently investigating unaffected family members position to PE occurs. Genetic study of the disease is an
and comparing phenotype of heterozygotes to that of enormous challenge because not only is female gender
non-carriers. and reproduction necessary to manifest the phenotype,
but consideration must be given to fetal-maternal and
Autosomal-recessive polycystic kidney disease fetal-paternal genotype interactions. A genetically sim-
A consanguineous Newfoundland family, with five plified isolate could be helpful in the study of PE, particu-
members who had congenital hepatic fibrosis and renal larly if the incidence of PE was high in the isolate and
disease of variable severity, was identified. The disease high relative risks of developing PE in sisters of probands
was linked to the ARPKD region on chromosome 6, with were observed. We decided to quantify the familial risk
a lod score of3.0 using microsatellite analysis. A novel, of PE in Newfoundland and to identify characteristics
large complex 300 base pair microsatellite was discovered. in probands that predict increased family risk, as a prelude
A recombination between D6S1024 and the ARPKD to a search for disease susceptibility genes [45]. Our molec-
gene in one of the siblings reduced the critical region to ular genetics partner in this project is Dr. Philip Marsden
in Toronto.560 kb between the new marker and D6S1714 (abstract;
A total of 5172 obstetric charts from ten hospitals wereFrost et al, J Am Soc Nephrol 11:389A, 2000), which
reviewed, representing 99% of deliveries on the island ofshould facilitate the discovery of the ARPKD gene.
Newfoundland for a one-year period from March 1996–
Primary hyperoxaluria 1997. These were evaluated for the diagnosis of PE ac-
cording to strict criteria. Family obstetric histories wereType I primary hyperoxaluria is an autosomal reces-
obtained from identified probands with PE. Sisters andsive disease with deficiency in the enzyme that enhances
mothers of probands were then interviewed and obstetricthe conversion of glyoxalate to -hydroxy-B-ketoadipic
charts reviewed to confirm the diagnosis of normal versusacid, leading to over excretion of glyoxylate, glycolate
preeclamptic pregnancy.and oxalate, and renal failure by the third decade. We
The incidence of PE in the population studied washave reported that the two patients with hyperoxaluria,
5.6% (N 292), and in primiparous women it was 7.9%.identified in Table 1, received kidneys from living related
Factors associated with increased risk of PE includeddonors, had excellent graft function after two years, and
primiparous delivery, multiple gestation, pregestationalfailed to accumulate oxalate in their transplants [42].
and gestational diabetes, and region of the province. OfGenetic studies were not undertaken.
330 sisters identified, 217 had 445 pregnancies with 327
charts located for review. The incidence of PE (basedDihydroxyadenine urolithiasis
on chart review) in 163 primiparous sisters was 20.4%.
Urolithiasis due to dihydroxyadenine (a poorly soluble The relative risk of PE in primiparous sisters of probands
purine) results from deficiency in the adenine salvage en- with PE compared to primiparous women in the popula-
zyme adenine phosphoribosyltransferase (APRT), which tion was 2.6. Factors in probands associated with a higher
produces high urinary levels of 2,8-dihydroxyadenine and risk of PE in sisters included proteinuria 1.0 g/L, dia-
crystalluria. The importance of the disorder includes the stolic blood pressure 110 mm Hg, hemolysis, elevated
following: it may lead to renal failure; its calculi are liver enzymes and low platelet count (HELLP) syn-
positive for uric acid with standard wet chemistry tests drome, and region of the province.
but not uricase tests; dihydroxyadenine can usually be This population-based study, using unbiased ascertain-
eliminated by allopurinol; and other family members can ment and strict diagnostic criteria, demonstrated a sig-
be affected. nificantly higher risk of PE in sisters of probands with
Two members of one Newfoundland family with PE, particularly when probands were defined by severity
APRT deficiency developed ESRD, recorded in Table 1. of pre-eclampsia (1 g/L proteinuria, diastolic BP 110
The index case was reported as the first North American mm Hg, or HELLP syndrome). This study demonstrates
white person identified with the condition [43]. Following that Newfoundland families at high risk of PE can be
identification of the APRT gene on chromosome 16q24.3, identified. Consequently, a study to search for suscepti-
a missense mutation in this gene was identified in our bility genes for PE has been initiated.
Non-proteinuric hypertension. Genetic effects on the lia-family that caused the dihydroxyadenine urolithiasis [44].
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for renal failure in first degree relatives of white patients with end-bility of developing non-proteinuric hypertension (NPH)
stage renal disease. A population based study. Am J Kidney Dis
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